- All sections
- C - Chemistrymetallurgy
- C07H - Sugarsderivatives thereofnucleosidesnucleotidesnucleic acids
- C07H 19/044 - Pyrrole radicals
Patent holdings for IPC class C07H 19/044
Total number of patents in this class: 53
10-year publication summary
|
5
|
2
|
1
|
1
|
1
|
0
|
0
|
2
|
4
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Avilar Therapeutics, Inc. | 28 |
6 |
| Gilead Sciences, Inc. | 2032 |
4 |
| Tianjin Hemay Oncology Pharmaceutical Co., Ltd. | 12 |
3 |
| Hoffmann-La Roche Inc. | 3405 |
2 |
| Japan Science and Technology Agency | 1329 |
2 |
| Eli Lilly and Company | 3834 |
2 |
| Gilead Pharmasset LLC | 40 |
2 |
| Riken | 1690 |
2 |
| Tagcyx Biotechnologies | 20 |
2 |
| Tianjin Hemay Bio-Tech Co., Ltd. | 25 |
2 |
| Asiros A/S | 10 |
2 |
| Novartis AG | 10867 |
1 |
| F. Hoffmann-La Roche AG | 7929 |
1 |
| Janssen Pharmaceutica N.V. | 3399 |
1 |
| Centre National de La Recherche Scientifique | 10414 |
1 |
| Board of Regents, The University of Texas System | 5772 |
1 |
| Bonac Corporation | 46 |
1 |
| Case Western Reserve University | 1812 |
1 |
| Consejo Superior de Investigaciones Cientificas (csic) | 1366 |
1 |
| Enanta Pharmaceuticals, Inc. | 428 |
1 |
| Other owners | 15 |